Stock DNA
Pharmaceuticals & Biotechnology
CNY 25,698 Million (Large Cap)
141.00
NA
0.59%
0.22
7.32%
6.08
Revenue and Profits:
Net Sales:
1,088 Million
(Quarterly Results - Dec 2025)
Net Profit:
-36 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.34%
0%
11.34%
6 Months
11.56%
0%
11.56%
1 Year
31.27%
0%
31.27%
2 Years
109.44%
0%
109.44%
3 Years
109.68%
0%
109.68%
4 Years
296.2%
0%
296.2%
5 Years
108.13%
0%
108.13%
Haisco Pharmaceutical Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.08%
EBIT Growth (5y)
-4.24%
EBIT to Interest (avg)
4.76
Debt to EBITDA (avg)
2.08
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
0.59
Tax Ratio
0.70%
Dividend Payout Ratio
117.53%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.05%
ROE (avg)
12.23%
Valuation key factors
Factor
Value
P/E Ratio
141
Industry P/E
Price to Book Value
14.96
EV to EBIT
376.71
EV to EBITDA
144.48
EV to Capital Employed
12.35
EV to Sales
15.33
PEG Ratio
NA
Dividend Yield
0.49%
ROCE (Latest)
3.28%
ROE (Latest)
10.63%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
1,087.60
970.10
12.11%
Operating Profit (PBDIT) excl Other Income
-113.70
-67.60
-68.20%
Interest
7.60
9.00
-15.56%
Exceptional Items
0.00
-0.00
Consolidate Net Profit
-35.70
14.20
-351.41%
Operating Profit Margin (Excl OI)
-174.70%
-138.10%
-3.66%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 12.11% vs -0.10% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is -351.41% vs -84.96% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
4,346.40
3,689.10
17.82%
Operating Profit (PBDIT) excl Other Income
459.10
406.60
12.91%
Interest
32.80
38.20
-14.14%
Exceptional Items
-5.30
0.20
-2,750.00%
Consolidate Net Profit
259.60
466.20
-44.32%
Operating Profit Margin (Excl OI)
40.40%
41.20%
-0.08%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 17.82% vs 11.08% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -44.32% vs 57.71% in Dec 2024
About Haisco Pharmaceutical Group Co., Ltd. 
Haisco Pharmaceutical Group Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






